These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20664783)

  • 1. Prospective factor analysis of alpha blocker monotherapy failure in benign prostatic hyperplasia.
    Hong KP; Byun YJ; Yoon H; Park YY; Chung WS
    Korean J Urol; 2010 Jul; 51(7):488-91. PubMed ID: 20664783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
    Jhang JF; Jiang YH; Kuo HC
    Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Adding Dutasteride to α-Blocker Therapy Treated Benign Prostatic Hyperplasia Patients with Small Volume Prostate (<30 mL).
    Hashimoto M; Shimizu N; Sugimoto K; Hongoh S; Minami T; Nozawa M; Yoshimura K; Hirayama A; Tahara H; Uemura H
    Low Urin Tract Symptoms; 2017 Sep; 9(3):157-160. PubMed ID: 26991643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of total prostate volume and transitional zone volume on the curative effect of transurethral resection of prostate in benign prostatic hyperplasia].
    Liu HM; Tian Y; Su ZY; Sun ZL; Luo GH
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):137-141. PubMed ID: 33455130
    [No Abstract]   [Full Text] [Related]  

  • 6. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of α-blocker monotherapy and α-blocker plus 5α-reductase inhibitor combination therapy based on prostate volume for treatment of benign prostatic hyperplasia.
    Joo KJ; Sung WS; Park SH; Yang WJ; Kim TH
    J Int Med Res; 2012; 40(3):899-908. PubMed ID: 22906262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study.
    Hong SJ; Ko WJ; Kim SI; Chung BH
    Eur Urol; 2003 Jul; 44(1):94-9; discussion 99-100. PubMed ID: 12814681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality.
    Gorgel SN; Sefik E; Kose O; Olgunelma V; Sahin E
    Int Braz J Urol; 2013; 39(5):657-62. PubMed ID: 24267123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis.
    Kim JH; Baek MJ; Sun HY; Lee B; Li S; Khandwala Y; Del Giudice F; Chung BI
    PLoS One; 2018; 13(10):e0203479. PubMed ID: 30281615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative observation of thulium laser resection of the prostate-tangerine technique and transurethral resection of the prostate for the treatment of benign prostatic hyperplasia of various sizes].
    Tian Y; Luo GH; Yang XS; Xia SJ; Sun ZL
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(6):423-427. PubMed ID: 30786335
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia.
    Kim HW; Moon DG; Kim HM; Hwang JH; Kim SC; Nam SG; Park JT
    Korean J Urol; 2011 Oct; 52(10):681-6. PubMed ID: 22087362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 980-Nm Diode Laser Vaporization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: Randomized Controlled Study.
    Cetinkaya M; Onem K; Rifaioglu MM; Yalcin V
    Urol J; 2015 Nov; 12(5):2355-61. PubMed ID: 26571321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-blocker monotherapy and α-blocker plus 5-alpha-reductase inhibitor combination treatment in benign prostatic hyperplasia; 10 years' long-term results.
    Shin TJ; Kim CI; Park CH; Kim BH; Kwon YK
    Korean J Urol; 2012 Apr; 53(4):248-52. PubMed ID: 22536467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature.
    Busetto GM; Del Giudice F; D'Agostino D; Romagnoli D; Minervini A; Rocco B; Antonelli A; Celia A; Schiavina R; Cindolo L; Chung BI; Kim JH; Maggi M; Sciarra A; De Berardinis E; Porreca A
    Arch Ital Urol Androl; 2020 Jan; 91(4):205-210. PubMed ID: 31937082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen.
    Cho HJ; Shin SC; Cho JM; Kang JY; Yoo TK
    Prostate Int; 2014 Dec; 2(4):196-202. PubMed ID: 25599076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications.
    Otaola-Arca H; Álvarez-Ardura M; Molina-Escudero R; Fernández MI; Páez-Borda Á
    Int Braz J Urol; 2021; 47(1):131-144. PubMed ID: 33047918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of lower urinary tract symptoms after discontinuation of 1 medication from 2-year combined alpha-blocker and 5-alpha-reductase inhibitor therapy for benign prostatic hyperplasia in men--a randomized multicenter study.
    Lin VC; Liao CH; Kuo HC
    Urology; 2014 Feb; 83(2):416-21. PubMed ID: 24332123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.